Pancreatic Cancer Research

ResearcherXijing HospitalNo recent work listed

Daiming Fan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2466-5002; OpenAlex author ID A5100715251. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 5

  1. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis. Last author DOI 10.1016/j.canlet.2021.09.026↗
  2. Ran GTPase protein promotes metastasis and invasion in pancreatic cancer by deregulating the expression of AR and CXCR4. Co-author DOI 10.4161/cbt.29217↗
  3. Ran GTPase protein promotes human pancreatic cancer proliferation by deregulating the expression of Survivin and cell cycle proteins. Co-author DOI 10.1016/j.bbrc.2013.09.079↗
  4. Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles. Last author DOI 10.1016/j.clinbiochem.2012.05.012↗
  5. CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells. Last author DOI 10.1002/mc.20737↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hao Liu · 1 shared paper, 2022 · strength 0.13
  2. Xiaoliang Gao · 1 shared paper, 2022 · strength 0.13
  3. Weijie Wang · 1 shared paper, 2022 · strength 0.13
  4. Xuegang Guo · 2 shared papers, 2013–2014 · strength 0.07
  5. Linhong Deng · 2 shared papers, 2013–2014 · strength 0.07
  6. Kaichun Wu · 2 shared papers, 2012–2013 · strength 0.06
  7. Lin Zhang · 1 shared paper, 2012 · strength 0.03
  8. Xiong Chen · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.